Belgium Data Desk › Health › Real world data collection on the efficacy and drug usage of BLINCYTO (blinatumomab)

Real world data collection on the efficacy and drug usage of BLINCYTO (blinatumomab)

Name: Real world data collection on the efficacy and drug usage of BLINCYTO (blinatumomab)
Creator: Amgen
License: https://opendatacommons.org/licenses/by/1-0/

This project concerns the registration of data on the healthdata.be platform related to the use of BLINCYTO. Amgen and RIZIV-INAMI agreed upon an article 81 procedure for which real world evidence of BLINCYTO needs to be collected in order to evaluate the product for future reimbursement. Reimbursement criteria for BLI

Publisher: Amgen
Licence: ODC-BY
Open licence — reuse allowed, usually with attribution
Topic: Health
Type: Dataset
Last updated (catalogue): 2026-08-11
Formats: HTML, CSV, JSON
Contact: medinfo-belux@amgen.com

Open in Belgium Data DeskPreview, profile and run SQL in your browser

Official page at the publisher ↗

Download link checked on 2026-10-04: 2 of 2 worked. This page describes catalogue information. It does not state that the data is correct.

Real world data collection on the efficacy and drug usage of BLINCYTO (blinatumomab)

More in this topic